Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Mathieu

Showing results (201-210 of 221) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African-Caribbean and Caucasian patientsSandy Figiel, Michelle Pinault, Isabelle Domingo, et al.
The French Journal of Urology|July 8, 2026
Prognostic Impact of Tumor Size in Low-Risk Upper Tract Urothelial Carcinoma: A Multi-Institutional AnalysisEléonore Petit, Idir Ouzaid, Mathieu Roumiguié, et al.
Journal of Clinical Medicine|March 25, 2022
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate CancersDiego Teyssonneau, Antoine Thiery-Vuillemin, Charles Dariane, et al.
BJU International|July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation studyRomain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
BJU International|March 6, 2018
Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre studyBenoît Peyronnet, Lauranne Tondut, Jean-Christophe Bernhard, et al.
Urologic Oncology|August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional studyRomain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
JCI Insight|November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancerSimpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.
World Journal of Urology|May 1, 2016
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional studyRicardo L Favaretto, Atessa Bahadori, Romain Mathieu, et al.
World Journal of Urology|December 15, 2015
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intentAurélie Mbeutcha, Ilaria Lucca, Vitaly Margulis, et al.
The Lancet Regional Health. Europe|July 7, 2023
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trialMarc Sapoval, Nicolas Thiounn, Aurélien Descazeaud, et al.
Pageof 23

Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African-Caribbean and Caucasian patientsSandy Figiel, Michelle Pinault, Isabelle Domingo, et al.
The French Journal of Urology|July 8, 2026
Prognostic Impact of Tumor Size in Low-Risk Upper Tract Urothelial Carcinoma: A Multi-Institutional AnalysisEléonore Petit, Idir Ouzaid, Mathieu Roumiguié, et al.
Journal of Clinical Medicine|March 25, 2022
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate CancersDiego Teyssonneau, Antoine Thiery-Vuillemin, Charles Dariane, et al.
BJU International|July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation studyRomain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
BJU International|March 6, 2018
Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre studyBenoît Peyronnet, Lauranne Tondut, Jean-Christophe Bernhard, et al.
Urologic Oncology|August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional studyRomain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
JCI Insight|November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancerSimpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.
World Journal of Urology|May 1, 2016
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional studyRicardo L Favaretto, Atessa Bahadori, Romain Mathieu, et al.
World Journal of Urology|December 15, 2015
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intentAurélie Mbeutcha, Ilaria Lucca, Vitaly Margulis, et al.
The Lancet Regional Health. Europe|July 7, 2023
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trialMarc Sapoval, Nicolas Thiounn, Aurélien Descazeaud, et al.
Pageof 23